Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNNGet Free Report) shares gapped up prior to trading on Monday . The stock had previously closed at $8.74, but opened at $10.17. Anbio Biotechnology shares last traded at $8.8980, with a volume of 371,901 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, July 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Anbio Biotechnology presently has an average rating of “Sell”.

Read Our Latest Stock Report on NNNN

Anbio Biotechnology Price Performance

The stock has a 50-day moving average price of $12.24 and a two-hundred day moving average price of $21.14.

Anbio Biotechnology Company Profile

(Get Free Report)

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.

Further Reading

Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.